ASTGY yields 11.11% · JNJ yields 2.13%● Live data
📍 ASTGY pulled ahead of the other in Year 1
Combined, ASTGY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASTGY + JNJ for your $10,000?
Hong Kong Aerospace Technology Group Limited, an investment holding company, provides electronics manufacturing services in the People's Republic of China, the United States, India, South Korea, Austria, Hong Kong, Brazil, Mexico, the United Kingdom, Germany, Vietnam, and Australia. The company provides design enhancement and verification; technical advice and engineering solutions; raw materials selection and procurement; quality control; logistic and delivery; and after-sale services for assembling and production of printed circuit board assemblies and fully-assembled electronic products for banking and finance, telecommunication, and smart device industries. Its fully-assembled electronic products include mobile phones, mobile point-of-sale, photovoltaic inverters, tablets, and street lamp controllers. It is also engaged in the sales of electronic products, satellite manufacturing, and satellite tracking and controlling services. Hong Kong Aerospace Technology Group Limited has a strategic cooperation agreement with the College of Engineering of City University of Hong Kong for the research and development of advanced satellite technology and related applications, such as communication systems, antenna technology, advanced materials, data processing, and energy management in Hong Kong. The company was formerly known as Eternity Technology Holdings Limited and changed its name to Hong Kong Aerospace Technology Group Limited in June 2021. The company was incorporated in 2003 and is based in Tseung Kwan O, Hong Kong. Hong Kong Aerospace Technology Group Limited is a subsidiary of Hong Kong Aerospace Technology Holdings Limited.
Full ASTGY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.